Both studies revealed significant reductions in HbA1c, insulin doses, and body weight, but higher rates of hypoglycemia and ketosis (ketone level >1.5 mmol/L), especially in the higher-dosed groups [62,63]. This evidence concerns the gene INS and Hypoglycemia.